Background: Atopic dermatitis (AD) represents the most common chronic inflammatory skin
Introduction
Atopic dermatitis (AD), named also eczema [1] , represents a common chronic inflammatory skin disease in childhood, with estimated prevalence up to 20% [2] .
The complex pathogenesis and interactions with environmental factors account for AD multifaceted course and its frequent association with allergic sensitization and other atopic diseases, such as food allergy, allergic rhinitis and asthma [3, 4] .
Coexistence of multiple allergic diseases has been widely observed in epidemiological studies [5] [6] [7] , as well as in clinical experience [8] . Coexistence with AD and food allergy has been estimated in about 35-40% of children, especially in those with early onset and more severe and persistent disease [9] . Previous population-based studies identified some individual and environmental risk factors, like urbanization and mold exposure, associated with an higher AD prevalence in Italian children and adolescents, thus providing important insights for prevention and interventions [10, 11] . Recently, the issues of comorbidity of allergy-related diseases and their interrelationships were investigated at population level, resulting in different comorbidity clusters at 4 and 8 years of age [3] . Moreover, few data are available about the different AD phenotypes, mainly based on the immunological and clinical differences between non IgE-associated and IgE-associated forms [8, 12, 13] .
Seo et al. in a recent study of 572 children under 3 years of age with AD identified four clusters of AD and demonstrated the heterogeneity of atopic dermatitis even in early childhood through a cluster analysis [14] . Age at onset, age at diagnosis, white blood cell count, eosinophil count, C-reactive protein and serum total immunoglobulin E level were the strongest predictors of cluster assignment [14] . Three AD phenotypes ("AD with low sensitization", "AD with multiple sensitizations", "AD with familial history of asthma") were identified through cluster analysis in infants aged less than 1 year, based on a mix of onset (within 2 years of age) and persistent symptoms showed to be more at risk to develop asthma and food allergy at 6 years of age [16] .
Although highlighting the importance of a comprehensive evaluation including asthma, allergic rhinitis and food allergy, most of the previous studies performing AD phenotyping are limited to young children and were aimed to predict allergic disease onset later in life [17] . Cross-sectional AD phenotypization based on both clinical manifestations of and comorbidities in different age groups needs to be performed to offer new perspectives in the interpretation of the disease and its proper management.
The present study aims to detect different AD phenotypes in preschool and school-age children, based on both clinical manifestations of AD and the presence of co-existing respiratory and food allergies, and to assess the relationship between the detected classes and host and environmental risk factors.
Methods

Study design and population
We performed a multicentre, cross-sectional study involving some of the main Italian paediatric allergy centres and other general paediatric centres located in nine Italian cities (Bologna, Messina, Napoli, Palermo, Parma, Pavia, Roma, Salerno and Torino).
children (age range 6-14 years), since such categorization is known to be clinically relevant for other associated diseases (i.e. allergic asthma) [20] .
Individual factors included self-reported breastfeeding (exclusive breastfeeding for >3 months) and parental history of eczema, asthma and rhinitis. Environmental factors included day-care attendance before the third year of life, current traffic exposure (moderate/high vs absent/low traffic intensity in the area of residence), early (during the first year of life) and current exposure to pets (dog/cat), maternal smoking during pregnancy, early (during the first year of life) and current exposure to passive smoke (mother/father), early (during the first year of life) and current exposure to mold (self-reported mold odor or visible mold) in the child sleeping room.
The number of self-reported AD exacerbations in the last 6 months was categorized into ≤ 3 or > 3 occurrences. Moreover, the questionnaire included self-reported information about the presence, in the last 6 months, of itching in the absence of lesions and night awakenings due to AD (>0 per week). Self-reported medication use in the last 6 months included: use of topical steroids and/or calcineurine inhibitors, topical antibiotics, antifungals and oral antihistamines. Self-reported activity limitations in the last 6 months included negative influence (moderate/heavy vs none/slight) of AD in sport, school attendance, sleep quality, recreation and social relations. Self-reported AD comorbidities in the last 6 months were grouped in the following macrocategories: lower respiratory comorbidities (wheezing, asthma or exercise-induced bronchoconstriction), upper respiratory comorbidities (allergic rhinitis or conjunctivitis or rhino-conjunctivitis) and food-induced comorbidities (urticaria, angioedema, oral allergic syndrome or anaphylaxis due to foods).
Asthma (or wheezing) was defined as a parent's report of physician diagnosis, as well as the occurrence of at least one between 1) use of medications or hospital admissions for asthma in the previous 6 months and 2) asthma or wheeze after physical exercise, or attacks of dyspnoea with wheeze, or dry cough/chest tightness with wheeze in the previous 6 months.
Asthma (or wheezing) control level was assessed according to GINA guidelines [20] .
Rhino-conjunctivitis was defined as a parent's report of symptoms (itchy, runny, or blocked nose without cold, associated with red itchy eyes) or a physician diagnosis of allergic rhinitis.
Food allergy was defined as a parent's report of 1) physician diagnosis of food allergy, as well as the occurrence of 2) allergic symptoms associated with food ingestion (urticaria, angioedema, oral allergic syndrome or anaphylaxis) with 3) evidence of food specific sensitization by skin test or detection of food-specific IgE. Urticaria, angioedema, oral allergic syndrome or anaphylaxis associated with food ingestion reported by parents not satisfying the above mentioned definition of food allergy were also considered separately as foodinduced comorbidities.
Statistical analysis
All the statistical analyses were performed in R 3.3.2, and were stratified by age group, i.e. A latent class analysis (LCA) was used to detect eczema phenotypes (R package poLCA) in the two age groups. The variables used for phenotyping referred both to clinical manifestations of eczema and to the presence of comorbidities: atopy, AD severity, AD exacerbations (last 6 months), itching in the absence of lesions (last 6 months), night awakenings due to AD (last 6 months), lower respiratory comorbidities (last 6 months), upper respiratory comorbidities (last 6 months) and food-induced comorbidities (last 6 months). The Akaike Information Criterion (AIC) was used to define the number of classes with the best fit to the data, with the smallest AIC representing the optimal model. Posterior probabilities of class membership were computed for each child and they were assigned to the class associated with the highest probability [21] .
Labels were assigned to the detected classes according to the different distributions of the phenotyping variables, which were compared graphically. The distributions of the sociodemographic characteristics, host and environmental factors were also compared among the detected classes through ANOVA (quantitative variables) or Fisher's exact (categorical labels were attributed to the classes detected for school-age children: Class 1 (n=40, 24%):
"moderate-severe AD, high comorbidity"; Class 2 (n=17, 10%): "moderate-severe AD, low comorbidity"; Class 3 (n=27, 16%): "mild AD, low comorbidity"; Class 4 (n=81, 49%): "mild AD, respiratory comorbidity". Differently from preschool-age children, the mild AD phenotype with food-induced comorbidities was not detected in school-age children; such comorbidities were frequently observed only in the moderate-severe comorbid phenotype (Class 1).
Overall, phenotypes 1 to 4 in school-age children were comparable to those in preschool-age children. However, the moderate-severe comorbid phenotype (Class 1) was more frequent in school-age children (24%) than in preschool-age children (8%). Moreover, the "mild, low comorbid AD" phenotype (Class 3) was substantially non-atopic (only 4% atopic) but more frequently associated to itch in the absence of lesions (41%) and upper respiratory comorbidities (56%) in school-age children. Table 2 summarizes the distribution of the variables listed in Table 1 respiratory comorbidity"). Day-care attendance before the third year of life was most frequent in Class 1 ("moderate-severe AD, high comorbidity") and less frequent in Class 3 ("mild AD, low comorbidity"). Mould exposure in the first year of life was more frequent in Class 1 ("moderate-severe AD, high comorbidity") than in other classes. No significant associations were observed in school-age children (Table 3) . Figure 3 represents the disease burden by AD phenotypes in the two age groups. Both in preschool and school-age children, medication use and daily activity limitations in the last 6 months were higher in moderate-severe AD phenotypes (Classes 1 and 2), and particularly in Class 1. In preschool children, the burden in terms of medication use was higher and quite similar in Class 1 ("moderate-severe AD, high comorbidity") and in Class 5 ("mild AD, foodinduced comorbidity"): oral antihistamines were used respectively in 94% and 70% of patients and topical steroids in 88% and 90% of patients in the last 6 months, but while in Class 1 the need to use of topical antibiotics was registered in 90% of patients, only 30% of patients of Class 5 used these drugs in the last 6 months. The disease burden in Class 1 ("moderate-severe AD, high comorbidity") was lower in school-age children: the main differences were observed in the use of topical antibiotics and in the limitation of daily activities (lighter colour intensities) (Figure 3) .
Socio-demographic characteristics, individual and environmental factors by class
AD phenotype burden
Discussion
The present cross-sectional study identified five different AD phenotypes in preschool-age severity (mild or moderate-severe) and the presence of atopic comorbidities. In preschool children, distinct classes characterized by respiratory or food-induced comorbidities were identified, while in schoolchildren the association with atopic comorbidities seemed to be independent from the comorbidity type.
The complexity of AD is due to both its multifaceted clinical manifestations and disease courses, so that sometimes it is difficult to distinguish if we are facing with a single illness or with a variety of illnesses, which may appear in overlapping moments. The knowledge of the clinical phenotype could be useful for the management of current symptoms (such as night awakenings and itch) and use of medications, but also to implement preventive measures to limit the development of comorbidities [22] .
The heterogeneity of atopic dermatitis has been demonstrated even in early childhood; in the study performed by Seo et al., four clusters of AD were identified in children aged less than 3 years by exploring the presence of 11 variables including both clinical and laboratory data [14] . A direct comparison between these phenotypes and our classes is not possible, because we analysed a population of different age and because our phenotypes characterization is mainly based on the clinical features and the presence of comorbidities and less on laboratory data.
In the recent PASTURE study, Roduit et al. identified four different phenotypes of eczema: early transient (9.2%), early persistent (6.5%), late onset (4.8%) and never/infrequent (7.5%) [16] . The phenotypes detected in the PASTURE study (longitudinal study) and in our study (cross-sectional) are not directly comparable since the study design is completely different and we focused on AD severity and comorbidities, rather than AD onset and persistence through years. For example, while asthma and rhinitis were mainly associated with early persistent eczema in the PASTURE study, such diseases were mainly associated with a more severe eczema (Class 1, moderate-severe AD, high comorbidity) or detected as main diseases with comorbid eczema (Class 4, mild AD, respiratory comorbidity) in our study.
Another recent work by Abuabara et al. applied the LCA approach to study the course of AD in a cohort of children treated with pimecrolimus (>6 weeks) [23] , identifying two main phenotypes related to the persistence or disappearance of the disease. Once again, the clinical phenotypes identified by Abuabara et al. [23] are not directly comparable with those of our study, due to the longitudinal design as well as the specific, long-term treatment.
Despite this, the different methodological approaches may become complementary in the clinical practice; while the longitudinal phenotypes may appear more informative when working with children in the first year of life, the cross-sectional information may be more interesting in managing preschoolers or schoolchildren. For example, in preschool children we observed the higher prevalence of respiratory symptoms among the two moderatesevere AD phenotypes (Class 1 and Class 2), this may suggest the importance of investigating the presence of respiratory signs and symptoms in patients with a moderate-severe AD.
Meanwhile, we observed that the higher burden in terms of medication use in preschool children is higher in the classes with more frequent exacerbations (Class 1 and 5), this may suggest the need to implement the daily skin care.
The genetic background (in particular parental history of eczema and asthma) seems to have a large influence in the preschool group being associated with the "moderate-severe AD, high comorbidity" phenotype (Class 1), while in the schoolchildren group this association is no longer found, probably due to the concomitance of many other risk factors in influencing AD phenotype.
In preschool children, the exposure to environmental risk factors, in particular mold exposure in the first year of life, was associated to Class 1 ("moderate-severe AD, high J Investig Allergol Clin Immunol 2020; Vol. 30 (2) © 2019 Esmon Publicidad doi: 10.18176/jiaci.0409 comorbidity"); this result is in agreement with previous finding in Italian children of SIDRIA study [11] . As also, having attended daycare before the third year of life resulted to be associated with the most severe phenotypes (Class 1).
The aforementioned risk factors have been also detected in a recent Asian mother-offspring cohort study, in which Authors found that maternal allergic history and attendance at a daycare centre increased the odds of the development of AD between 6 and 12 months [24] .
As expected, activity limitations (sport, school attendance and recreation) were higher in "moderate-severe" classes (1 and 2), as well as sleep quality and social relation. The level of drug consumption was also higher in these phenotypes, maybe due to a higher susceptibility to skin infections, especially by S. Aureus. Therefore, the severity of the disease have a The main weaknesses concerns the study design that is: i) questionnaire-based so that some of the self-reported data might be not confirmed, and ii) cross-sectional and therefore lacking in follow-up data, such as information on possible transitions from one phenotype to another over time. Further follow-up studies are needed to analyse the clinical evolution of patients with the identified phenotypes. 
